Physician profile
Amit Goyal
NPI 1104828300
$6,927.37
in general payments reported to CMS, 2019-2025
26 companies · $695 in 2025
The $695 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $314 · 2021: $559 · 2022: $348 · 2023: $2,686 · 2024: $2,133 · 2025: $695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,915 · Travel and Lodging: $1,598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,915.02 |
| Travel and Lodging | $1,598.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,773.53 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Biotronik Nro, INC. | $1,174.07 | 2023-2025 | Prospera, Biotronik |
| Medtronic, INC. | $613.39 | 2021-2024 | Onyx Frontier, Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $371.96 | 2022-2024 | Xarelto |
| Shockwave Medical, INC | $348.41 | 2021-2025 | |
| Acist Medical Systems, INC. | $313.78 | 2020 | |
| Abbott Laboratories | $288.19 | 2023 | Mitraclip, Coroflow, Absolute Pro |
| Amgen INC. | $146.18 | 2022-2023 | Repatha |
| Philips North America LLC | $114.29 | 2022 | |
| Penumbra, INC. | $81.21 | 2019 | |
| Cardiac Dimensions, INC. | $78.88 | 2023 | |
| Inari Medical, INC. | $71.23 | 2021 | |
| Angiodynamics, INC. | $66.19 | 2023 | Angiovac |
| Novartis Pharmaceuticals Corporation | $61.10 | 2019 | |
| Genentech USA, INC. | $60.79 | 2022-2024 | Xolair |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $56.39 | 2023 | Opticross |
| Sanofi-Aventis U.S. LLC | $50.31 | 2019 | |
| Cook Medical LLC | $48.78 | 2023 | Zenith Alpha |
| Janssen Scientific Affairs, LLC | $46.33 | 2022 | |
| Cardiva Medical, INC. | $43.14 | 2022 | |
| Globus Medical, INC. | $40.03 | 2024 | Creo Mis Stabilization System, Excelsiusgps Robotic Navigation System |
| Cardiovascular Systems INC. | $35.61 | 2021-2022 | |
| Teleflex LLC | $27.82 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.76 | 2023 | Camzyos |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Goyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.